GEN Exclusives

More »

GEN News Highlights

More »
Oct 13, 2010

Lundbeck Pays Genmab €7.5 Up Front in Deal Focused on CNS Diseases

Lundbeck Pays Genmab €7.5 Up Front in Deal Focused on CNS Diseases

Development and commercialization milestones will add another €38 million. [© Markus Schnatmann - Fotolia.com]

  • Lundbeck is paying Genmab €7.5 million (roughly $10.5 million) up front as part of a collaboration agreement to develop antibody therapeutics for CNS diseases. Under terms of the collaboration Genmab will generate antibodies against three Lundbeck targets. If all development and commercialization milestones are achieved Genmab could earn another €38 million.

    Lundbeck retains the option to take resulting antibodies through clinical development for relevant indications and will be responsible for all associated costs. The company will also have access to its partner’s antibody generation and development expertise and therapeutic antibody platforms. Genmab in addition retains an option to take selected antibodies into clinical development for cancer indications, at its own cost, in return for paying Lundbeck milestones and royalties.

    Genmab CEO, Jan van de Winkel, says that the deal “gives Genmab the opportunity to leverage our antibody technology and expertise and to expand our pipeline into a new and exciting therapeutic area without assuming a financial obligation.”

    Peter Hongaard Anderson, evp and head of research at Lundbeck adds, “The new partnership follows Lundbeck’s new R&D strategy to ensure we have the most efficient platform for the future discovery and development of drugs that will be able to help and treat biologically defined groups of patients with brain diseases.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Lab-Grown Vaginas

Which body part do you think will be successfully engineered in the lab next?